IP Library Granted Patent US 12,295,881
Granted Patent B2
US 12,295,881 · App. 16/972,085 · Granted May 13, 2025

Topical ocular delivery devices and methods for using the same

Inventor: Yehuda Ivri (Newport Coast, CA)
Assignee: Bausch + Lomb Ireland Limited
A61F9/0008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,295,881
App. No.
16/972,085
Granted
May 13, 2025
Kind
B2
Abstract

Topical ocular delivery devices are provided. Aspects of the devices include a transducer configured to oscillate at an amplitude and frequency that provides for an emitted stream velocity which results in minimal discomfort during topical ocular delivery. Also provided are methods of using the devices, e.g., in topical ocular delivery applications.

Claims (32)

1. A fluid delivery device, the device comprising:

(a) a fluid package comprising:

(i) a reservoir comprising an ophthalmic formulation; and

(ii) an aperture through which the ophthalmic formulation can be directed, the aperture having a diameter ranging from 200 to 350 μm;

(b) a pin member being in axial alignment with the aperture and engaging the reservoir; and

(c) an electromagnetic actuator configured to axially oscillate the pin member while imparting pressure fluctuations to the fluid to eject fluid from the reservoir through the aperture at a velocity in a range from 10 to 500 cm/sec, which results in minimal discomfort during topical ocular delivery;

wherein the electromagnetic actuator comprises an electromagnet and a permanent magnet in operational proximity to each other; and

wherein the permanent magnet is positioned at a first region of a cantilever beam and the electromagnetic actuator further comprises an anchor positioned at a second region of the cantilever beam and configured to transmit oscillatory displacement force to an external surface of the fluid package.

2. The fluid delivery device according to claim 1 , wherein the electromagnetic actuator imparts pressure fluctuations in the fluid by displacement induced on an external surface of the fluid package.

3. The fluid delivery device according to claim 1 , wherein the electromagnetic actuator oscillates at an audible frequency in a range from 20 to 20,000 Hz.

4. The fluid delivery device according to claim 3 , wherein the audible frequency ranges from 800 to 1200 Hz.

5. The fluid delivery device according to claim 1 , wherein the electromagnetic actuator is configured to operate at an oscillation amplitude ranging from 2 to 3 μm.

6. The fluid delivery device according to claim 1 , wherein the device is configured to eject fluid through the aperture as a stream having a velocity ranging from 50 to 150 cm/s.

7. The fluid delivery device according to claim 1 , further comprising an image-based alignment system configured to align fluid ejected through the aperture with a target ocular location.

8. The fluid delivery device according to claim 1 , wherein the fluid package and electromagnetic actuator are present in a housing.

9. The fluid delivery device according to claim 8 , wherein the housing comprises a cover positioned along the housing, wherein the cover is configurable between an open position, in which the aperture is exposed, and a closed position, in which the aperture is not exposed.

10. A method of delivering a fluid to a topical ocular location of a subject, the method comprising:

(a) aligning a fluid delivery device according to claim 1 with the topical ocular location; and

(b) activating the electromagnetic actuator to eject fluid from the reservoir through the aperture to the topical ocular location at a velocity which results in minimal discomfort during topical ocular delivery.

11. A kit comprising a fluid delivery device according to claim 1 .

12. A fluid delivery device, the device comprising:

(a) a fluid package comprising:

(i) a reservoir configured to hold a fluid; and

(ii) an aperture through which the fluid can be directed;

(b) a pin member being in axial alignment with the aperture and engaging the reservoir; and

(c) an electromagnetic actuator configured to axially oscillate the pin member while imparting pressure fluctuations to the fluid to eject the fluid from the reservoir through the aperture;

wherein the electromagnetic actuator comprises an electromagnet and a permanent magnet in operational proximity to each other; and

wherein the permanent magnet is positioned at a first region of a cantilever beam and the electromagnetic actuator further comprises an anchor positioned at a second region of the cantilever beam and configured to transmit oscillatory displacement force to an external surface of the fluid package.

13. The fluid delivery device according to claim 12 , wherein the fluid package and actuator are present in a housing.

14. The fluid delivery device according to claim 13 , wherein the housing comprises a cover positioned along the housing, wherein the cover is configurable between an open position, in which the aperture is exposed, and a closed position, in which the aperture is not exposed.

15. The fluid delivery device according to claim 12 , further comprising an image-based alignment system configured to align fluid ejected through the aperture with a target ocular location.

16. The fluid delivery device according to claim 15 , where the image-based alignment system is a concave mirror.

Assignments (8)
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (066694/0131) Recorded Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072460/0655 →
PATENT SECURITY AGREEMENT Recorded Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 29, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 066707/0684 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 27, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066694/0131 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2023
From: NOVARTIS AG
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 065531/0583 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNMENT AGREEMENT PREVIOUSLY RECORDED ON REEL 062116 FRAME 0917. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jul 10, 2023
From: KEDALION THERAPEUTICS, INC.
To: NOVARTIS AG
Reel/Frame 064237/0507 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2022
From: KEDALION THERAPEUTICS, INC.
To: NOVARTIS AG
Reel/Frame 062116/0917 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2020
From: IVRI, YEHUDA
To: KEDALION THERAPEUTICS, INC.
Reel/Frame 054542/0960 →
Continuity (2)
Provisional Application 62693818 · Jul 3, 2018
Related Publication 20210220169A1 · Jul 22, 2021
References Cited (352)
US 3640274A · Costello · 1972 [cited by applicant]
US 3779245A · Windsor · 1973 [cited by examiner]
US 3812854A · Michaels et al. · 1974 [cited by applicant]
US 3861386A · Harris · 1975 [cited by applicant]
US 3934585A · Maurice · 1976 [cited by applicant]
US 3970250A · Drews · 1976 [cited by applicant]
US 3976072A · Walker · 1976 [cited by applicant]
US 4159803A · Cameto · 1979 [cited by applicant]
US 4300546A · Kruber · 1981 [cited by applicant]
US 4334531A · Reichl · 1982 [cited by applicant]
US 4338576A · Takahashi et al. · 1982 [cited by applicant]
US 4344744A · Schuster et al. · 1982 [cited by applicant]
US 4352459A · Berger · 1982 [cited by applicant]
US 4465234A · Maehara · 1984 [cited by applicant]
US 4632311A · Nakane · 1986 [cited by applicant]
US 4655393A · Berger · 1987 [cited by applicant]
US 4793339A · Matsumoto et al. · 1988 [cited by applicant]
US 4850534A · Takahashi · 1989 [cited by applicant]
US 4882150A · Kaufman · 1989 [cited by applicant]
US 4952581A · Bito · 1990 [cited by applicant]
US 4961345A · Tsuruoka · 1990 [cited by applicant]
US 4976259A · Higson · 1990 [cited by applicant]
US 4981625A · Rhim · 1991 [cited by applicant]
US 5025957A · Ranalletta · 1991 [cited by applicant]
US 5171306A · Vo · 1992 [cited by applicant]
US 5232363A · Meller · 1993 [cited by applicant]
US 5368582A · Bertera · 1994 [cited by applicant]
US 5370317A · Weston · 1994 [cited by applicant]
US 5487378A · Robertson · 1996 [cited by applicant]
US 5549249A · Foster · 1996 [cited by applicant]
US 5624057A · Lifshey · 1997 [cited by applicant]
US 5627611A · Scheiner · 1997 [cited by applicant]
US 5630793A · Rowe · 1997 [cited by examiner]
US 5657926A · Toda · 1997 [cited by applicant]
US 5692651A · Fuchs · 1997 [cited by applicant]
US 5811443A · DeSantis, Jr. · 1998 [cited by applicant]
US 5828394A · Khuri-Yakub et al. · 1998 [cited by applicant]
US 5938117A · Ivri · 1999 [cited by applicant]
US 5958342A · Gamble · 1999 [cited by applicant]
US 5960224A · Sanada et al. · 1999 [cited by applicant]
US 6024717A · Ball · 2000 [cited by examiner]
US 6062212A · Davison · 2000 [cited by applicant]
US 6065623A · Hierzer · 2000 [cited by applicant]
US 6095376A · Hennemann · 2000 [cited by applicant]
US 6196218B1 · Voges · 2001 [cited by applicant]
US 6232129B1 · Wiktor · 2001 [cited by applicant]
US 6273092B1 · Nolan · 2001 [cited by applicant]
US 6302101B1 · Py · 2001 [cited by applicant]
US 6467476B1 · Ivri · 2002 [cited by applicant]
US RE38077E · Cohen · 2003 [cited by applicant]
US 6543442B2 · Gonda · 2003 [cited by applicant]
US 6629646B1 · Ivri · 2003 [cited by applicant]
US 6730066B1 · Bennwik · 2004 [cited by applicant]
US 6758837B2 · Peclat · 2004 [cited by applicant]
US 6869275B2 · Dante et al. · 2005 [cited by applicant]
US 7066398B2 · Borland · 2006 [cited by applicant]
US 7105357B1 · Kalkum · 2006 [cited by applicant]
US 7201732B2 · Anderson · 2007 [cited by applicant]
US 7314938B2 · Shen · 2008 [cited by applicant]
US 7571722B2 · Wuttke · 2009 [cited by applicant]
US 7745460B2 · Shen · 2010 [cited by applicant]
US 7790743B2 · Shen · 2010 [cited by applicant]
US 7874467B2 · Pardes · 2011 [cited by applicant]
US 7883031B2 · Collins, Jr. · 2011 [cited by applicant]
US 7928122B2 · Shen · 2011 [cited by applicant]
US 8012136B2 · Collins, Jr. · 2011 [cited by applicant]
US 8048047B2 · Domash · 2011 [cited by applicant]
US 8056766B2 · Grevin · 2011 [cited by applicant]
US 8128606B2 · Anderson · 2012 [cited by applicant]
US 8133210B2 · Al-Abdulla · 2012 [cited by applicant]
US 8144399B2 · Steenblik · 2012 [cited by applicant]
US 8168655B2 · Gadek · 2012 [cited by applicant]
US 8273307B2 · Eickhoff · 2012 [cited by applicant]
US 8367701B2 · Burnier · 2013 [cited by applicant]
US 8398001B2 · Borland · 2013 [cited by applicant]
US 8435544B2 · Mitra · 2013 [cited by applicant]
US 8544462B2 · Papania · 2013 [cited by applicant]
US 8545463B2 · Collins, Jr. · 2013 [cited by applicant]
US 8592450B2 · Gadek · 2013 [cited by applicant]
US 8629111B2 · Acheampong · 2014 [cited by applicant]
US 8633162B2 · Acheampong · 2014 [cited by applicant]
US 8642556B2 · Acheampong · 2014 [cited by applicant]
US 8648048B2 · Acheampong · 2014 [cited by applicant]
US 8684980B2 · Hunter · 2014 [cited by applicant]
US 8685930B2 · Acheampong · 2014 [cited by applicant]
US 8722728B2 · Wong · 2014 [cited by applicant]
US 8733935B2 · Ballou, Jr. et al. · 2014 [cited by applicant]
US 8863998B2 · Painchaud · 2014 [cited by applicant]
US 8927574B2 · Burnier · 2015 [cited by applicant]
US 8927921B1 · Nelms · 2015 [cited by applicant]
US 8936021B2 · Collins, Jr. · 2015 [cited by applicant]
US 9039666B2 · Voss · 2015 [cited by applicant]
US 9068566B2 · Ivri · 2015 [cited by applicant]
US 9085553B2 · Zeller · 2015 [cited by applicant]
US 9087145B2 · Ballou, Jr. · 2015 [cited by applicant]
US 9186690B2 · Scanlon · 2015 [cited by applicant]
US 9216174B2 · Shen · 2015 [cited by applicant]
US 9238532B2 · Decock · 2016 [cited by applicant]
US 9248191B2 · Acheampong · 2016 [cited by applicant]
US 9353088B2 · Burnier · 2016 [cited by applicant]
US 9447077B2 · Burnier · 2016 [cited by applicant]
US 9597230B2 · Haffner · 2017 [cited by applicant]
US 9676525B2 · Greiner-Perth · 2017 [cited by applicant]
US 9700686B2 · Gavini · 2017 [cited by applicant]
US 9801757B2 · Voss · 2017 [cited by applicant]
US 9808825B2 · Aguilar · 2017 [cited by applicant]
US 9867933B2 · Pardes · 2018 [cited by applicant]
US 9890141B2 · Burnier · 2018 [cited by applicant]
US 10073949B2 · Ballou, Jr. · 2018 [cited by applicant]
US 10105720B2 · Decock · 2018 [cited by applicant]
US 10124000B2 · Shen · 2018 [cited by applicant]
US 10154923B2 · Hunter · 2018 [cited by applicant]
US 10174017B2 · deLong · 2019 [cited by applicant]
US 10314740B2 · Kraft · 2019 [cited by applicant]
US 10624781B2 · Ivri · 2020 [cited by applicant]
US 11278448B2 · Palanker · 2022 [cited by applicant]
US 20010035184A1 · Schuler et al. · 2001 [cited by applicant]
US 20010036424A1 · Takahashi · 2001 [cited by applicant]
US 20010036449A1 · Garst · 2001 [cited by applicant]
US 20020078947A1 · Gumaste · 2002 [cited by applicant]
US 20020124843A1 · Skiba · 2002 [cited by applicant]
US 20020158196A1 · Berggren · 2002 [cited by applicant]
US 20020161344A1 · Peclat · 2002 [cited by applicant]
US 20020185125A1 · Klimowicz · 2002 [cited by applicant]
US 20020190079A1 · Hamamoto · 2002 [cited by applicant]
US 20030052573A1 · Wischnewskiy · 2003 [cited by applicant]
US 20030065294A1 · Pickup · 2003 [cited by applicant]
US 20030071071A1 · Garcia · 2003 [cited by applicant]
US 20030140921A1 · Smith · 2003 [cited by applicant]
US 20040039355A1 · Gonzalez · 2004 [cited by applicant]
US 20040050861A1 · Lisec · 2004 [cited by applicant]
US 20040138630A1 · Al-Abdulla · 2004 [cited by applicant]
US 20040163645A1 · Connelly · 2004 [cited by applicant]
US 20040173642A1 · Clifford · 2004 [cited by applicant]
US 20040204674A1 · Anderson · 2004 [cited by applicant]
US 20040215157A1 · Peclat · 2004 [cited by applicant]
US 20040256487A1 · Collins · 2004 [cited by applicant]
US 20040263567A1 · Hess et al. · 2004 [cited by applicant]
US 20050001981A1 · Anderson · 2005 [cited by applicant]
US 20050006417A1 · Nicol · 2005 [cited by applicant]
US 20050107832A1 · Bernabei · 2005 [cited by applicant]
US 20050172962A1 · Gumaste · 2005 [cited by applicant]
US 20050207917A1 · Koerner et al. · 2005 [cited by applicant]
US 20050240162A1 · Chen · 2005 [cited by applicant]
US 20050261641A1 · Warchol · 2005 [cited by applicant]
US 20060065677A1 · Py · 2006 [cited by applicant]
US 20060069358A1 · Gerondale · 2006 [cited by applicant]
US 20060147313A1 · Zengerle · 2006 [cited by applicant]
US 20060210604A1 · Dadey et al. · 2006 [cited by applicant]
US 20070051362A1 · Sullivan · 2007 [cited by applicant]
US 20070088267A1 · Shekalim · 2007 [cited by applicant]
US 20070088268A1 · Edwards · 2007 [cited by applicant]
US 20070102455A1 · Stark · 2007 [cited by applicant]
US 20070119969A1 · Collins · 2007 [cited by applicant]
US 20070195151A1 · Anderson · 2007 [cited by applicant]
US 20070268340A1 · Dacquay · 2007 [cited by applicant]
US 20070295332A1 · Ziegler et al. · 2007 [cited by applicant]
US 20080039807A1 · Pine · 2008 [cited by applicant]
US 20080202514A1 · Kriksunov · 2008 [cited by applicant]
US 20080214940A1 · Benaron · 2008 [cited by applicant]
US 20080233053A1 · Gross · 2008 [cited by applicant]
US 20080247264A1 · Gabl · 2008 [cited by applicant]
US 20080257911A1 · Choi · 2008 [cited by applicant]
US 20090060793A1 · Eickhoff · 2009 [cited by applicant]
US 20090114742A1 · Collins, Jr. · 2009 [cited by applicant]
US 20090134235A1 · Ivri · 2009 [cited by applicant]
US 20090182291A1 · Eilat · 2009 [cited by applicant]
US 20090192443A1 · Collins, Jr. · 2009 [cited by applicant]
US 20090212127A1 · Reynolds · 2009 [cited by applicant]
US 20090212133A1 · Collins, Jr. · 2009 [cited by applicant]
US 20090223513A1 · Papania · 2009 [cited by applicant]
US 20100001090A1 · Neergaard · 2010 [cited by applicant]
US 20100005903A1 · Beavis · 2010 [cited by applicant]
US 20100013352A1 · Pletner · 2010 [cited by applicant]
US 20100044460A1 · Sauzade · 2010 [cited by applicant]
US 20100072301A1 · Cater · 2010 [cited by applicant]
US 20100072302A1 · Cater · 2010 [cited by applicant]
US 20100076388A1 · Cater · 2010 [cited by applicant]
US 20100147899A1 · Nardi · 2010 [cited by applicant]
US 20100186738A1 · Kobayashi et al. · 2010 [cited by applicant]
US 20100222752A1 · Collins, Jr. · 2010 [cited by applicant]
US 20100295420A1 · Wierach · 2010 [cited by applicant]
US 20100326431A1 · Yu · 2010 [cited by applicant]
US 20110074247A1 · Hohlfeld · 2011 [cited by applicant]
US 20110102735A1 · Gupta · 2011 [cited by applicant]
US 20110106025A1 · Hall · 2011 [cited by applicant]
US 20110146670A1 · Gallem et al. · 2011 [cited by applicant]
US 20110284579A1 · Pardes · 2011 [cited by applicant]
US 20110293452A1 · Kim · 2011 [cited by applicant]
US 20110305425A1 · Fabrykowski et al. · 2011 [cited by applicant]
US 20120017898A1 · Moller · 2012 [cited by applicant]
US 20120062840A1 · Ballou, Jr. · 2012 [cited by applicant]
US 20120070467A1 · Ballou, Jr. · 2012 [cited by applicant]
US 20120143152A1 · Hunter · 2012 [cited by applicant]
US 20120179122A1 · Eilat · 2012 [cited by applicant]
US 20120197219A1 · Scanlon · 2012 [cited by applicant]
US 20120304929A1 · Ivri · 2012 [cited by examiner]
US 20130002095A1 · Van der Linden · 2013 [cited by applicant]
US 20130017283A1 · Zemel · 2013 [cited by applicant]
US 20130025038A1 · Frey · 2013 [cited by examiner]
US 20130053042A1 · Tanikawa · 2013 [cited by applicant]
US 20130079733A1 · Burt et al. · 2013 [cited by applicant]
US 20130118619A1 · Loth · 2013 [cited by applicant]
US 20130140225A1 · Decock · 2013 [cited by applicant]
US 20130150812A1 · Hunter · 2013 [cited by applicant]
US 20130152796A1 · Pawl · 2013 [cited by applicant]
US 20130153677A1 · Leen · 2013 [cited by applicant]
US 20130164436A1 · Yagi et al. · 2013 [cited by applicant]
US 20130172830A1 · Hunter · 2013 [cited by applicant]
US 20130206857A1 · Ivri · 2013 [cited by applicant]
US 20130299607A1 · Wilkerson · 2013 [cited by applicant]
US 20130345672A1 · Ferreri · 2013 [cited by applicant]
US 20140088524A1 · Marx · 2014 [cited by applicant]
US 20140113946A1 · Abad · 2014 [cited by applicant]
US 20140157956A1 · Date · 2014 [cited by applicant]
US 20140171490A1 · Gross · 2014 [cited by applicant]
US 20140187969A1 · Hunter · 2014 [cited by examiner]
US 20140214024A1 · Eichler · 2014 [cited by applicant]
US 20140224267A1 · Levitz · 2014 [cited by applicant]
US 20140242022A1 · Vehige · 2014 [cited by applicant]
US 20140249491A1 · Ballou, Jr. · 2014 [cited by applicant]
US 20140257172A1 · Yalamanchili · 2014 [cited by applicant]
US 20140274910A1 · Cumberlidge · 2014 [cited by applicant]
US 20140276054A1 · Hossack · 2014 [cited by applicant]
US 20140285121A1 · Balogh · 2014 [cited by applicant]
US 20140323931A1 · Avni · 2014 [cited by applicant]
US 20140336596A1 · Wochele · 2014 [cited by applicant]
US 20140336618A1 · Wilkerson · 2014 [cited by applicant]
US 20150018781A1 · Rinderknect · 2015 [cited by applicant]
US 20150035180A1 · Shen · 2015 [cited by applicant]
US 20150036219A1 · Shen · 2015 [cited by applicant]
US 20150040891A1 · Avni · 2015 [cited by applicant]
US 20150086397A1 · Ma · 2015 [cited by applicant]
US 20150097050A1 · Ciervo · 2015 [cited by applicant]
US 20150139973A1 · Steinfeld · 2015 [cited by applicant]
US 20150144128A1 · Hijlkema · 2015 [cited by applicant]
US 20150209174A1 · Abreu · 2015 [cited by applicant]
US 20150209178A1 · Blakey · 2015 [cited by applicant]
US 20150238689A1 · Shimizu · 2015 [cited by applicant]
US 20150256730A1 · Shen · 2015 [cited by applicant]
US 20150276994A1 · Shen · 2015 [cited by applicant]
US 20150308421A1 · Vogt · 2015 [cited by applicant]
US 20150328151A1 · Ballou, Jr. · 2015 [cited by applicant]
US 20150352297A1 · Stedman · 2015 [cited by applicant]
US 20160107180A1 · Decock · 2016 [cited by applicant]
US 20160120833A1 · Wan · 2016 [cited by applicant]
US 20160129467A1 · Ciardella · 2016 [cited by applicant]
US 20160199225A1 · Ivri · 2016 [cited by applicant]
US 20160199230A1 · Doshi · 2016 [cited by applicant]
US 20160213866A1 · Tan · 2016 [cited by applicant]
US 20160263314A1 · Pardes · 2016 [cited by applicant]
US 20160296367A1 · Ivri · 2016 [cited by examiner]
US 20160354559A1 · Gavini · 2016 [cited by examiner]
US 20170028626A1 · Delrot · 2017 [cited by applicant]
US 20170136484A1 · Wilkerson · 2017 [cited by applicant]
US 20170138357A1 · Kondo et al. · 2017 [cited by applicant]
US 20170151088A1 · Ballou, Jr. · 2017 [cited by applicant]
US 20170156927A1 · Richter · 2017 [cited by applicant]
US 20170182510A1 · Wilkerson · 2017 [cited by applicant]
US 20170187969A1 · Kitamori · 2017 [cited by applicant]
US 20170274159A1 · Gavini · 2017 [cited by applicant]
US 20170344714A1 · Ballou, Jr. · 2017 [cited by applicant]
US 20180085251A1 · Hunter · 2018 [cited by applicant]
US 20180108275A1 · Newberry · 2018 [cited by applicant]
US 20180116871A1 · Hunter · 2018 [cited by applicant]
US 20180207030A1 · Ivri · 2018 [cited by applicant]
US 20180229247A1 · Laidler · 2018 [cited by applicant]
US 20180236466A1 · Laidler · 2018 [cited by applicant]
US 20180297053A1 · Buckland · 2018 [cited by applicant]
US 20190053945A1 · Hunter · 2019 [cited by applicant]
US 20190074086A1 · Ballou, Jr. · 2019 [cited by applicant]
US 20190099071A1 · Ehrmann · 2019 [cited by applicant]
US 20190314195A1 · Ivri · 2019 [cited by applicant]
US 20190314196A1 · Ivri · 2019 [cited by applicant]
US 20190314197A1 · Ivri · 2019 [cited by applicant]
US 20190314198A1 · Ivri · 2019 [cited by applicant]
US 20200022416A1 · Alarcon · 2020 [cited by applicant]
US 20200197218A1 · Newell · 2020 [cited by examiner]
US 20200197220A1 · Ivri · 2020 [cited by applicant]
US 20200246182A1 · Ivri · 2020 [cited by applicant]
US 20200281768A1 · Quintana · 2020 [cited by applicant]
US 20200315842A1 · Palanker · 2020 [cited by examiner]
US 20200330267A1 · Li · 2020 [cited by examiner]
US 20210128350A1 · Ivri · 2021 [cited by applicant]
US 20210137732A1 · Quintana · 2021 [cited by applicant]
US 20210322209A1 · Ivri · 2021 [cited by applicant]
US 20210322210A1 · Ivri · 2021 [cited by applicant]
US 20220039998A1 · Ivri · 2022 [cited by applicant]
US 20220125631A1 · Ianchulev · 2022 [cited by applicant]
US 20220160542A1 · Palanker · 2022 [cited by applicant]
US 20220192874A1 · Ivri · 2022 [cited by applicant]
CN 103118642A · 2013 [cited by applicant]
CN 104146816A · 2014 [cited by applicant]
CN 104582647A · 2015 [cited by applicant]
CN 204813955U · 2015 [cited by examiner]
CN 105351426A · 2016 [cited by applicant]
CN 107530509A · 2018 [cited by applicant]
EP 0622035A1 · 1994 [cited by applicant]
EP 0622035B1 · 1999 [cited by applicant]
EP 1493410A2 · 2005 [cited by applicant]
JP H08251948A · 1996 [cited by applicant]
JP 3055480U · 1999 [cited by applicant]
JP 2007531577A · 2007 [cited by applicant]
JP 2013535250A · 2013 [cited by applicant]
KR 101258025B1 · 2013 [cited by applicant]
KR 1020130054352A · 2013 [cited by applicant]
WO 1994020875A3 · 1995 [cited by applicant]
WO 1996000050A1 · 1996 [cited by applicant]
WO 2000005482A1 · 2000 [cited by applicant]
WO 2001046134A1 · 2001 [cited by applicant]
WO 2002072169A2 · 2002 [cited by applicant]
WO WO02072169A2 · 2002 [cited by examiner]
WO 2010078428A1 · 2010 [cited by applicant]
WO 2012009706A1 · 2012 [cited by applicant]
WO 2013076682A1 · 2013 [cited by applicant]
WO 2013090459A1 · 2013 [cited by applicant]
WO 2013090468A1 · 2013 [cited by applicant]
WO 2013155201A2 · 2013 [cited by applicant]
WO 2013158967A3 · 2013 [cited by applicant]
WO 2016115050A1 · 2016 [cited by applicant]
WO 2016164830A1 · 2016 [cited by applicant]
WO 2018136618A2 · 2018 [cited by applicant]
WO 2018227190A1 · 2018 [cited by applicant]
WO 2019113483A1 · 2019 [cited by applicant]
WO 2020010116A1 · 2020 [cited by applicant]
Abidi et al., “Lifilegrast: A Novel Drug for Treatment of Dry Eye Disease”, Journal of Pharmacology and Pharmacotherapy, 2016, vol. 7, pp. 194-198. [cited by applicant]
Ali et al., “Glaucoma and Dry Eye”, Ophthalmology, 2009, vol. 116, p. 1232. [cited by applicant]
Birkhoff et al., “New Devices for Dispensing Ophthalmic Treatments May Be the Key to Managing the Life Cycles of Established Products”, 2010, Drug Delivery Technology, vol. 10, pp. 16-21. [cited by applicant]
Brenton, “CRUK/10/30: TRICON8—Sample collection of ovarian cancer tissues and blood for translational research from patients participating in the CR-UK/MRC ICON8 trial”, 2015, online abstract. [cited by applicant]
Choi et al., “Generation of Controllable Monodispersed Sprays Using Impulse Jet and Charging Techniques”, Review of Scientific Instruments, 1990, vol. 61, pp. 1689-1693. [cited by applicant]
Denion et al., “A 5-Minute Interval between Two Dilating Eye Drops Increases Their Effect”, Jul. 19, 2017, Optometry and Vision Science, vol. 94, pp. 838-844. [cited by applicant]
Electronic Tutorials, “Linear Solenoid Actuator”, 2016 [online]; [Retrieved on Oct. 17, 2022], Retrieved from the Internet URL: https://www.electronics-tutorials.ws/io/io_6.html. [cited by applicant]
Elert, Glenn, “Spherical mirrors”, The Physics Hypertextbook, 2021 [online]; [Retrieved on Oct. 17, 2022], Retrieved from the Internet URL: https://physics.info/mirrors/. [cited by applicant]
Gannon, Megan, “The Best Length for Eyelashes, According to Science”, Feb. 24, 2015 [online]; [Retrieved on Oct. 17, 2022], Retrieved from the Internet URL: https://www.livescience.com/49934-optimal-length-for-eyelashes… [cited by applicant]
Ianchulev et al., “Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper”, 2016, Ther. Deliv., vol. 7, pp. 751-760. [cited by applicant]
Jow et al., “Design and Optimization of Printed Spiral Coils for Efficient Transcutaneous Inductive Power Transmission”, IEEE Transactions on Biomedical Circuits and Systems, 2007, vol. 1, pp. 193-202. [cited by applicant]
Kent, Christopher, “Getting Meds onto the Eye, 21st Century Style”, Mar. 15, 2013 [online]; [Retrieved on Aug. 27, 2019], Retrieved from the Internet URL: https://www.reviewofophthalmology.com/article/getting-meds-onto-… [cited by applicant]
Kompella et al., “ISOPT Clinical Hot Topic Panel Discussion on Ocular Drug Delivery”, 2019, J. Ocul. Pharmacol. Ther., vol. 35, pp. 457-465. [cited by applicant]
Lallemand et al., “Cyclosporine A Delivery to the Eye: A Comprehensive Review of Academic and Industrial Efforts”, European Journal of Pharmaceutics and Biopharmaceutics, 2017, vol. 117, pp. 14-28. [cited by applicant]
Lindblad et al., “Production of Uniform-Sized Liquid Droplets”, Journal of Scientific Instruments, 1965, vol. 42, pp. 635-638. [cited by applicant]
Lux et al., “A Comparative Bioavailability Study of Three Conventional Eye Drops Versus a Single Lyophilisate”, Br. J. Ophthalmol., 2003, vol. 87, pp. 436-440. [cited by applicant]
Macmillan Online Dictionary, “Stream,” n.d. [online]; [Retrieved on Dec. 13, 2018]; Retrieved from the Internet URL: https://macmillandictionary.com/dictionary/american/stream_ 1#stream_9. [cited by applicant]
Marx et al., “Opthalmic Squeeze Dispenser: Eliminating the Need for Additives in Multidose Preservative-Free Eyecare Formulations”, 2017, Drug Development Delivery, vol. 17, pp. 40-44. [cited by applicant]
Merriam-Webster, “Clamp,” 2019 [online]; [Retrieved on Oct. 25, 2022], Retrieved from the Internet URL: https://www.merriam-webster.com/dictionary/clamp. [cited by applicant]
Merriam-Webster, “Collimate,” 2020 [online]; [Retrieved on Oct. 17, 2022], Retrieved from the Internet URL: https://www.merriam-webster.com/dictionary/collimated. [cited by applicant]
Merriam-Webster, “Stream,” n.d. [online]; [Retrieved on Dec. 13, 2018], Retrieved from the Internet URL: https://www.merriam-webster.com/dictionary/stream. [cited by applicant]
Murube et al., “Classification of Artificial Tears, I: Composition and Properties”, Advanced Experimental Medical Biology, 1998, vol. 438, pp. 693-704. [cited by applicant]
Murube et al., “Classification of Artificial Tears, II: Additives and Commercial Formulas”, Advanced Experimental Medical Biology, 1998, vol. 438, pp. 705-715. [cited by applicant]
Oxford Online Dictionary, “Stream,” n.d. [online]; [Retrieved on Dec. 13, 2018]; Retrieved from the Internet URL: https://en.oxforddictionaries.com/definition/us/stream. [cited by applicant]
Pronin et al., “Teaching an Old Drug New Tricks: Agonism, Antagonism, and Biased Signaling of Pilocarpine through M3 Muscarinic Acetylcholine Receptor”, 2017, Mol. Pharmacol., vol. 92, pp. 601-612. [cited by applicant]
Vocabulary.com, “Stream,” n.d. [online]; [Retrieved on Dec. 13, 2018]; Retrieved from the Internet URL: https://www.dictionary.com/stream. [cited by applicant]
International Search Report and Written Opinion dated Sep. 24, 2019 in corresponding International Patent Application No. PCT/US2019/040354 (8 pages). [cited by applicant]